{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:37:42Z","timestamp":1782949062704,"version":"3.54.5"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Respiratory tract exacerbations play a crucial role in progressive lung damage of people with cystic fibrosis, representing a major determinant in the loss of functional lung tissue, quality of life and patient survival. Detection and monitoring of respiratory tract exacerbations are challenging for clinicians, since under- and over-treatment convey several risks for the patient. Although various diagnostic and monitoring tools are available, their implementation is hampered by the current definition of respiratory tract exacerbation, which lacks objective \u201ccut-offs\u201d for clinical and lung function parameters. In particular, the latter shows a large variability, making the current 10% change in spirometry outcomes an unreliable threshold to detect exacerbation. Moreover, spirometry cannot be reliably performed in preschool children and new emerging tools, such as the forced oscillation technique, are still complementary and need more validation. Therefore, lung imaging is a key in providing respiratory tract exacerbation-related structural and functional information. However, imaging encompasses several diagnostic options, each with different advantages and limitations; for instance, conventional chest radiography, the most used radiological technique, may lack sensitivity and specificity in respiratory tract exacerbations diagnosis. Other methods, including computed tomography, positron emission tomography and magnetic resonance imaging, are limited by either radiation safety issues or the need for anesthesia in uncooperative patients. Finally, lung ultrasound has been proposed as a safe bedside option but it is highly operator-dependent and there is no strong evidence of its possible use during respiratory tract exacerbation. This review summarizes the clinical challenges of respiratory tract exacerbations in patients with cystic fibrosis with a special focus on imaging. Firstly, the definition of respiratory tract exacerbation is examined, while diagnostic and monitoring tools are briefly described to set the scene. This is followed by advantages and disadvantages of each imaging technique, concluding with a diagnostic imaging algorithm for disease monitoring during respiratory tract exacerbation in the cystic fibrosis patient.<\/jats:p>","DOI":"10.3389\/fped.2022.1084313","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T06:45:28Z","timestamp":1675665928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of respiratory tract exacerbations in people with cystic fibrosis: Focus on imaging"],"prefix":"10.3389","volume":"10","author":[{"given":"Nicholas","family":"Landini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Ciet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hettie M.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mattone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Majo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gramegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Fabio","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm A. W. M.","family":"Tiddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Morana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"210173","DOI":"10.1183\/16000617.0173-2021","article-title":"State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the \u201ciMAging managEment of cySTic fibROsis\u201d (MAESTRO) consortium","volume":"31","author":"Ciet","year":"2022","journal-title":"Eur Respir Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1055\/s-0039-1697975","article-title":"Acute pulmonary exacerbations in cystic fibrosis","volume":"40","author":"Goss","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.chest.2020.09.084","article-title":"Pulmonary exacerbations in adults with cystic fibrosis","volume":"159","author":"Stanford","year":"2021","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.chest.2020.06.044","article-title":"BAL Inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis","volume":"158","author":"Ishak","year":"2020","journal-title":"Chest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jcf.2017.04.003","article-title":"Standardized treatment of pulmonary exacerbations (STOP) study: physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary exacerbations","volume":"16","author":"West","year":"2017","journal-title":"J Cyst Fibros"},{"key":"B6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2214\/ajr.163.3.8079843","article-title":"Radiographic changes in acute exacerbations of cystic fibrosis in adults: a pilot study","volume":"163","author":"Greene","year":"1994","journal-title":"Am J Roentgenol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"10.1007\/s00247-022-05522-4","DOI":"10.1007\/s00247-022-05522-4","article-title":"Chest radiography and computed tomography imaging in cystic fibrosis: current challenges and new perspectives [published online ahead of print, 2022 Oct 29]","author":"Ciet","year":"2022","journal-title":"Pediatr Radiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12890-021-01728-8","article-title":"Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation","volume":"21","author":"Hassanzad","year":"2021","journal-title":"BMC Pulm Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1378\/chest.98.5.1081","article-title":"Quality of well-being before and after antibiotic treatment of pulmonary exacerbation in patients with cystic fibrosis","volume":"98","author":"Orenstein","year":"1990","journal-title":"Chest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1378\/chest.121.1.64","article-title":"Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis","volume":"121","author":"Britto","year":"2002","journal-title":"Chest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ppul.21090","article-title":"Healthcare expenditures for privately insured people with cystic fibrosis","volume":"44","author":"Ouyang","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1164\/rccm.200202-087OC","article-title":"Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality","volume":"166","author":"Mayer-Hamblett","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4155\/cli.11.174","article-title":"Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease","volume":"2","author":"VanDevanter","year":"2012","journal-title":"Clin Investig (Lond)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1067\/mpd.2001.117288","article-title":"Defining a pulmonary exacerbation in cystic fibrosis","volume":"139","author":"Rosenfeld","year":"2001","journal-title":"J Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis\u20131: epidemiology and pathogenesis","volume":"62","author":"Goss","year":"2007","journal-title":"Thorax"},{"key":"B20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/ppul.22652","article-title":"Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis","volume":"48","author":"Wagener","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","article-title":"Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials","volume":"10","author":"Bilton","year":"2011","journal-title":"J Cyst Fibros"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1164\/rccm.202102-0461OC","article-title":"A randomized clinical trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment","volume":"204","author":"Goss","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.3390\/ijms21165882","article-title":"From ivacaftor to triple combination: a systematic review of efficacy and safety of CFTR modulators in people with cystic fibrosis","volume":"21","author":"Gramegna","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/s0140-6736(88)91613-3","article-title":"Reliability of eliciting physical signs in examination of the chest","volume":"1","author":"Spiteri","year":"1988","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/ppul.25925","article-title":"Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis","volume":"57","author":"Bouzek","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/ppul.25250","article-title":"Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic","volume":"56","author":"Patel","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S1569-1993(22)00594-X","DOI":"10.1016\/j.jcf.2022.06.007","article-title":"Comparative analysis of respiratory symptom scores to detect acute respiratory events in children with cystic fibrosis [published online ahead of print, 2022 Jun 23]","author":"Perrem","year":"2022","journal-title":"J Cyst Fibros"},{"key":"B30","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.201207-1160oe","article-title":"Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/thx.2005.043372","article-title":"Improving rate of decline of FEV1 in young adults with cystic fibrosis","volume":"61","author":"Que","year":"2006","journal-title":"Thorax"},{"key":"B32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1183\/09031936.00159111","article-title":"Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis","volume":"40","author":"Waters","year":"2012","journal-title":"Eur Respir J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/resp.12382","article-title":"Putting lung function and physiology into perspective: cystic fibrosis in adults","volume":"20","author":"Horsley","year":"2015","journal-title":"Respirology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e20210237","DOI":"10.36416\/1806-3756\/e20210237","article-title":"Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV1 decline","volume":"48","author":"Aquino","year":"2022","journal-title":"J Bras Pneumol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpeds.2015.08.042","article-title":"Forced expiratory volume in 1\u2005s variability helps identify patients with cystic fibrosis at risk of greater loss of lung function [published correction appears in J Pediatr. (2018) 197:322]","volume":"169","author":"Morgan","year":"2016","journal-title":"J Pediatr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1164\/arrd.1982.126.1.31","article-title":"Serial changes in pulmonary functions in children hospitalized with cystic fibrosis","volume":"126","author":"Redding","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ppul.1950160404","article-title":"Predictive value of pulmonary function testing during pulmonary exacerbations in cystic fibrosis","volume":"16","author":"Rosenberg","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1164\/rccm.201001-0057OC","article-title":"Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes","volume":"182","author":"Collaco","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ppul.21374","article-title":"Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis","volume":"46","author":"Sanders","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12890-017-0546-8","article-title":"Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis","volume":"17","author":"Hoppe","year":"2017","journal-title":"BMC Pulm Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1183\/09031936.03.00006603","article-title":"Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis","volume":"23","author":"de Jong","year":"2004","journal-title":"Eur Respir J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/thx.2007.077784","article-title":"Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis","volume":"63","author":"Gustafsson","year":"2008","journal-title":"Thorax"},{"key":"B43","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ppul.22651","article-title":"Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting","volume":"48","author":"Singer","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1573398X17666211201092525","article-title":"Lung clearance index: a new measure of ventilation inhomogeneity in childhood respiratory diseases","volume":"17","author":"Parisi","year":"2021","journal-title":"Curr Respir Med Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/thx.2007.082628","article-title":"Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis","volume":"63","author":"Horsley","year":"2008","journal-title":"Thorax"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2003380","DOI":"10.1183\/13993003.03380-2020","article-title":"Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis","volume":"58","author":"Stanojevic","year":"2021","journal-title":"Eur Respir J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1164\/rccm.202006-2433OC","article-title":"Lung clearance index to track acute respiratory events in school-age children with cystic fibrosis","volume":"203","author":"Perrem","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.3390\/jcm10214884","article-title":"Lung clearance index in children with cystic fibrosis during pulmonary exacerbation","volume":"10","author":"Walicka-Serzysko","year":"2021","journal-title":"J Clin Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/thoraxjnl-2017-210979","article-title":"Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis","volume":"73","author":"Rayment","year":"2018","journal-title":"Thorax"},{"key":"B50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fped.2018.00403","article-title":"Respiratory bacterial culture sampling in expectorating and non-expectorating patients with cystic fibrosis","volume":"6","author":"Eyns","year":"2018","journal-title":"Front Pediatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ppul.23636","article-title":"Induced sputum to detect lung pathogens in young children with cystic fibrosis","volume":"52","author":"D\u2019Sylva","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1016\/j.jcf.2021.04.015","article-title":"Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients","volume":"21","author":"Kos","year":"2022","journal-title":"J Cyst Fibros"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ppul.25712","article-title":"A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis","volume":"57","author":"Caudri","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/1573398X15666190521112824","article-title":"Biomarkers in pediatric lung diseases including cystic fibrosis","volume":"15","author":"Parisi","year":"2019","journal-title":"Curr Respir Med Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1164\/rccm.200306-731OC","article-title":"Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis","volume":"168","author":"Ordo\u00f1ez","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ppul.20237","article-title":"Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy","volume":"40","author":"Colombo","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1164\/rccm.200609-1354OC","article-title":"Association between pulmonary function and sputum biomarkers in cystic fibrosis","volume":"175","author":"Mayer-Hamblett","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jcf.2021.10.009","article-title":"Inflammation biomarkers in sputum for clinical trials in cystic fibrosis: current understanding and gaps in knowledge","volume":"21","author":"Lepissier","year":"2022","journal-title":"J Cyst Fibros"},{"key":"B60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/thorax.55.3.205","article-title":"Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis","volume":"55","author":"Montuschi","year":"2000","journal-title":"Thorax"},{"key":"B61","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.freeradbiomed.2008.06.026","article-title":"Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis","volume":"45","author":"Lucidi","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1399-3038.2007.00693.x","article-title":"Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children","volume":"19","author":"Robroeks","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"046007","DOI":"10.1088\/1752-7163\/ab670d","article-title":"Relevance between clinical status and exhaled molecules related to neutrophilic inflammation in pediatric cystic fibrosis","volume":"14","author":"Toprak Kan\u0131k","year":"2020","journal-title":"J Breath Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"896439","DOI":"10.3389\/fped.2022.896439","article-title":"Metabolomic biomarkers to predict and diagnose cystic fibrosis pulmonary exacerbations: a systematic review","volume":"10","author":"Nguyen","year":"2022","journal-title":"Front Pediatr"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1378\/chest.13-0693","article-title":"Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations","volume":"144","author":"Shoki","year":"2013","journal-title":"Chest"},{"key":"B66","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2466-14-150","article-title":"Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis","volume":"14","author":"Gir\u00f3n-Moreno","year":"2014","journal-title":"BMC Pulm Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jcf.2010.01.005","article-title":"Sputum and serum calprotectin are useful biomarkers during CF exacerbation","volume":"9","author":"Gray","year":"2010","journal-title":"J Cyst Fibros"},{"key":"B68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1164\/rccm.201407-1365LE","article-title":"Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis","volume":"191","author":"Reid","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1513\/AnnalsATS.201410-493OC","article-title":"Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation","volume":"12","author":"Sagel","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"B70","doi-asserted-by":"publisher","first-page":"293053","DOI":"10.1155\/2015\/293053","article-title":"The role of serine proteases and antiproteases in the cystic fibrosis lung","volume":"2015","author":"Twigg","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B71","doi-asserted-by":"publisher","first-page":"W533","DOI":"10.2214\/AJR.12.9354","article-title":"Common blind spots on chest CT: where are they all hiding? Part 1\u2013airways, lungs, and pleura","volume":"201","author":"Wu","year":"2013","journal-title":"Am J Roentgenol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1148\/radiol.212641","article-title":"Use of dynamic chest radiography to assess treatment of pulmonary exacerbations in cystic fibrosis","volume":"303","author":"FitzMaurice","year":"2022","journal-title":"Radiology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ppul.23787","article-title":"Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography","volume":"52","author":"Kuo","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1007\/s00330-017-4819-7","article-title":"Diagnosis of bronchiectasis and airway wall thickening in children with cystic fibrosis: objective airway-artery quantification","volume":"27","author":"Kuo","year":"2017","journal-title":"Eur Radiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1164\/rccm.200603-343OC","article-title":"Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis","volume":"175","author":"Davis","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/thoraxjnl-2012-202342","article-title":"Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age","volume":"68","author":"Byrnes","year":"2013","journal-title":"Thorax"},{"key":"B77","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00330-020-07095-y","article-title":"Predictive value of the modified Bhalla score for assessment of pulmonary exacerbations in adults with cystic fibrosis","volume":"31","author":"Diab-C\u00e1ceres","year":"2021","journal-title":"Eur Radiol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2214\/ajr.169.2.9242738","article-title":"High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation","volume":"169","author":"Shah","year":"1997","journal-title":"Am J Roentgenol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1164\/rccm.201311-2099CI","article-title":"Monitoring cystic fibrosis lung disease by computed tomography. Radiation risk in perspective","volume":"189","author":"Kuo","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2214\/AJR.19.22694","article-title":"Best practices: imaging strategies for reduced-dose chest CT in the management of cystic fibrosis-related lung disease","volume":"217","author":"Sheahan","year":"2021","journal-title":"Am J Roentgenol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00247-022-05468-7","article-title":"Dual-source computed tomography protocols for the pediatric chest\u2014scan optimization techniques [published online ahead of print, 2022 Aug 11]","author":"Rapp","year":"2022","journal-title":"Pediatr Radiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1164\/rccm.201501-0061OC","article-title":"PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis","volume":"191","author":"Rosenow","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2100844","DOI":"10.1183\/13993003.00844-2021","article-title":"Artificial intelligence in computed tomography for quantifying lung changes in the era of CFTR modulators","volume":"59","author":"Dournes","year":"2022","journal-title":"Eur Respir J"},{"key":"B84","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1007\/s00330-016-4218-5","article-title":"Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution","volume":"26","author":"Dournes","year":"2016","journal-title":"Eur Radiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00330-015-3850-9","article-title":"Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT","volume":"26","author":"Ciet","year":"2016","journal-title":"Eur Radiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"10.1097\/RTI.0000000000000637","DOI":"10.1097\/RTI.0000000000000637","article-title":"Ultrashort echo-time magnetic resonance imaging sequence in the assessment of systemic sclerosis-interstitial lung disease. [published online ahead of print, 2022 Feb 04]","author":"Landini","year":"2022","journal-title":"J Thorac Imaging"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/jmri.26212","article-title":"3D Ultrashort echo time MRI of the lung using stack-of-spirals and spherical k -space coverages: evaluation in healthy volunteers and parenchymal diseases","volume":"48","author":"Dournes","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"B88","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1148\/radiol.15141655","article-title":"Quiet submillimeter MR imaging of the lung is feasible with a PETRA sequence at 1.5\u2005T","volume":"276","author":"Dournes","year":"2015","journal-title":"Radiology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e200611","DOI":"10.1148\/ryct.2021200611","article-title":"T2-weighted lung imaging using a 0.55-T MRI system","volume":"3","author":"Campbell-Washburn","year":"2021","journal-title":"Radiol Cardiothorac Imaging"},{"key":"B90","doi-asserted-by":"publisher","first-page":"110515","DOI":"10.1016\/j.ejrad.2022.110515","article-title":"Low-field 0.55\u2005T MRI for assessment of pulmonary groundglass and fibrosis-like opacities: inter-reader and inter-modality concordance [published online ahead of print, 2022 Sep 8]","volume":"156","author":"Azour","year":"2022","journal-title":"Eur J Radiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1601437","DOI":"10.1183\/13993003.01437-2016","article-title":"Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging","volume":"50","author":"Ciet","year":"2017","journal-title":"Eur Respir J"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1007\/s00330-016-4248-z","article-title":"Diffusion weighted imaging in cystic fibrosis disease: beyond morphological imaging","volume":"26","author":"Ciet","year":"2016","journal-title":"Eur Radiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1148\/radiol.2019190797","article-title":"Quantification of MRI T2-weighted high signal volume in cystic fibrosis: a pilot study","volume":"294","author":"Benlala","year":"2020","journal-title":"Radiology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1164\/rccm.201309-1659OC","article-title":"Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease","volume":"189","author":"Wielp\u00fctz","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00247-015-3420-y","article-title":"Magnetic resonance imaging in children: common problems and possible solutions for lung and airways imaging","volume":"45","author":"Ciet","year":"2015","journal-title":"Pediatr Radiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2003104","DOI":"10.1183\/13993003.03104-2020","article-title":"Free-breathing MRI for monitoring ventilation changes following antibiotic treatment of pulmonary exacerbations in paediatric cystic fibrosis","volume":"57","author":"Munidasa","year":"2021","journal-title":"Eur Respir J"},{"key":"B97","doi-asserted-by":"publisher","first-page":"10.1007\/s00247-022-05470-z","DOI":"10.1007\/s00247-022-05470-z","article-title":"Safety considerations related to intravenous contrast agents in pediatric imaging [published online ahead of print, 2022 Aug 9]","author":"Cheeney","year":"2022","journal-title":"Pediatr Radiol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1002\/ppul.23266","article-title":"Respiratory tract exacerbations revisited: ventilation, inflammation, perfusion, and structure (VIPS) monitoring to redefine treatment: respiratory tract exacerbations revisited","volume":"50","author":"Tiddens","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00247-021-05062-3","article-title":"Strategies to perform magnetic resonance imaging in infants and young children without sedation","volume":"52","author":"Harrington","year":"2022","journal-title":"Pediatr Radiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00247-017-3871-4","article-title":"Pediatric anesthesia and neurotoxicity: what the radiologist needs to know","volume":"48","author":"Barton","year":"2018","journal-title":"Pediatr Radiol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.rcl.2019.08.005","article-title":"Imaging of diffuse lung disease in the intensive care unit patient","volume":"58","author":"Stefanidis","year":"2020","journal-title":"Radiol Clin North Am"},{"key":"B102","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/diagnostics12040838","article-title":"What is COVID 19 teaching us about pulmonary ultrasound?","volume":"12","author":"Soldati","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B103","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.4103\/jcecho.jcecho_59_2","article-title":"The role of imaging in COVID-19 pneumonia diagnosis and management: main positions of the experts, key imaging features and open answers","volume":"30","author":"Landini","year":"2020","journal-title":"J Cardiovasc Echogr"},{"key":"B104","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/2397198320970394","article-title":"The role of ultrasound in systemic sclerosis: on the cutting edge to foster clinical and research advancement","volume":"6","author":"Hughes","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/diagnostics12071696","article-title":"Lung ultrasound B-lines in the evaluation of the extent of interstitial lung disease in systemic sclerosis","volume":"12","author":"Bruni","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4187\/respcare.07038","article-title":"The use of ultrasound as a tool to evaluate pulmonary disease in cystic fibrosis","volume":"65","author":"Peixoto","year":"2020","journal-title":"Respir Care"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e0215786","DOI":"10.1371\/journal.pone.0215786","article-title":"Diagnostic value of chest ultrasound in children with cystic fibrosis\u2013pilot study","volume":"14","author":"Strzelczuk-Judka","year":"2019","journal-title":"PLoS One"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1084313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T15:53:46Z","timestamp":1713369226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1084313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":107,"alternative-id":["10.3389\/fped.2022.1084313"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1084313","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"article-number":"1084313"}}